Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $291.46, Implies 9% Upside
Analysts have raised the 12-month average price target for Charles River Laboratories International, Inc. (CRL) stock from $285.54 to $291.46, implying a 9% potential upside based on its August 7th closing price. The consensus rating from 19 analysts remains "Buy," with a majority recommending …